Search

for
Search:

Glossary

Similar Terms

Erythropoietin

Learn

0 / 0 results

— no results

Research

5 / 129 results

Skin Regeneration with Conical and Hair Follicle Structure of Deep Second-Degree Scalding Injuries via Combined Expression of the EPO Receptor and Beta Common Receptor by Local Subcutaneous Injection of Nanosized rhEPO

research Skin Regeneration with Conical and Hair Follicle Structure of Deep Second-Degree Scalding Injuries via Combined Expression of the EPO Receptor and Beta Common Receptor by Local Subcutaneous Injection of Nanosized rhEPO

15 citations, March 2012 in “International journal of nanomedicine”

Local injections of nanosized rhEPO can speed up skin healing and improve quality after deep second-degree burns.

UK High Court Revokes Escitalopram Patent; Validity of Second Medical Use Claims Based on Dosage Regimes; Stay of Proceedings Pending EPO Opposition

research UK High Court Revokes Escitalopram Patent; Validity of Second Medical Use Claims Based on Dosage Regimes; Stay of Proceedings Pending EPO Opposition

July 2007 in “Journal of Generic Medicines”

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

research Recent European Legal Developments on Second Medical Uses and Dosage Regimes

2 citations, September 2012 in “Pharmaceutical patent analyst”

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

research Human Hair Follicles Are an Extrarenal Source and a Nonhematopoietic Target of Erythropoietin

71 citations, May 2007 in “The FASEB journal”

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

research Generic Competition And Pharmaceutical Patent Strategies: A Sequel

October 2008 in “Journal of Intellectual Property Law & Practice”

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

View more "epo-r" in research →

Community Join

1 / 1 results

community HLT Megathread on HMI-115 (key takeaways in comments)

in Research/Science 39 upvotes 1 year ago

HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.